Key result
Catestatin is a promising biomarker reflecting sympathetic nervous system activity, with its levels correlating with heart failure severity and prognosis.
Design
Literature review
Authors
Loading...
May aid HF risk stratification; leaves open prospective validation before clinical adoption.
Catestatin may serve as a valuable biomarker for risk stratification and assessing sympathetic overactivation in patients with heart failure.
Meshcheryakov et al. (2021) conducted a review in Heart failure. Catestatin was evaluated. Catestatin is a promising biomarker reflecting sympathetic nervous system activity, with its levels correlating with heart failure severity and prognosis.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: